Transcriptomics and proteomics of projection neurons in a circuit linking hippocampus with dorsolateral prefrontal cortex in human brain

Rahul A Bharadwaj,Christopher Borcuk,Gianluca C Kikidis,Leonardo Sportelli,Alessandro Bertolino,Robert N Cole,Lauren DeVine,Joel E Kleinman,Brady Maher,Srinidhi R Sripathy,Vamshi Mallepalli,Madhur Parihar,JooHeon Shin,YongKyu Lee,Carly Montoya,Amy Deep-Soboslay,Thomas M Hyde,Daniel R Weinberger,Giulio Pergola

DOI: https://doi.org/10.1101/2024.06.12.598714

2024-06-13

Abstract:RNA-sequencing studies of brain tissue homogenates have shed light on the molecular processes underlying schizophrenia (SCZ) but lack biological granularity at the cell type level. Laser capture microdissection (LCM) can isolate selective cell populations with intact cell bodies to allow complementary gene expression analyses of mRNA and protein. We used LCM to collect excitatory neuron-enriched samples from CA1 and subiculum (SUB) of the hippocampus and layer III of the dorsolateral prefrontal cortex (DLPFC), from which we generated gene, transcript, and peptide level data. In a machine learning framework, LCM-derived expression achieved superior regional identity predictions as compared to bulk tissue, with further improvements when using isoform-level transcript and protein quantifications. LCM-derived co-expression also had increased co-expression strength of neuronal gene sets compared to tissue homogenates. SCZ risk co-expression pathways were identified and replicated across transcript and protein networks and were consistently enriched for glutamate receptor complex and post-synaptic functions. Finally, through inter-regional co-expression analyses, we show that CA1 to SUB transcriptomic connectivity may be altered in SCZ.

Neuroscience

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to study the projection neurons in the connection circuits between the hippocampus and the dorsolateral prefrontal cortex (DLPFC) in the human brain through transcriptomics and proteomics techniques, in order to better understand the molecular mechanisms of schizophrenia (SCZ). Specifically, the authors used laser - capture microdissection (LCM) technology to collect excitatory neuron - enriched samples from the CA1 and subiculum (SUB) regions of the hippocampus and the third layer of the DLPFC, generating data at the gene, transcript, and peptide levels. Through these data, the authors hope:

1. **Improve cell - type - specific expression analysis**: Traditional tissue homogenate RNA sequencing studies lack cell - type specificity, while LCM technology can isolate specific cell populations, thereby providing more accurate gene expression and protein expression data.

2. **Enhance regional identity prediction**: In the machine - learning framework, LCM - derived expression data shows better performance in regional identity prediction than whole - tissue data, especially when using transcript and protein quantification.

3. **Identify SCZ - risk co - expression pathways**: Through co - expression network analysis, identify pathways related to SCZ risk, and validate these pathways in the transcriptome and proteome networks, and find that these pathways are significantly enriched in glutamate receptor complexes and postsynaptic functions.

4. **Explore cross - regional transcriptome connectivity**: Through cross - regional co - expression analysis, study whether the transcriptome connectivity from CA1 to SUB is altered in SCZ.

In summary, this paper aims to deeply analyze the molecular mechanisms of SCZ through high - resolution cell - type - specific data, especially focusing on the neuronal connections between the hippocampus and the DLPFC and their changes in the disease.